Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis [PDF]
Dieter Adam +4 more
core +1 more source
Targeting TNFR1-driven necroptosis in breast cancer. [PDF]
Rafeeq M +7 more
europepmc +1 more source
PANoptosis: a potential target of cardiomyopathy. [PDF]
Sun M, Lu C, Wei J, Gao C, Dong D.
europepmc +1 more source
Trigger Points of Necroptosis (RIPK1, RIPK3, and MLKL)-Promising Horizon or Blind Alley in Therapy of Colorectal Cancer? [PDF]
Sokołowski M, Butrym A.
europepmc +1 more source
A positive effect of selenoprotein on mammary gland: Selenoprotein P stabilizes tight junctions by reducing cell death through inflammation mitigation in mice. [PDF]
Zhu M +5 more
europepmc +1 more source
Resident alveolar macrophages are highly susceptible to the induction of RIPK1/RIPK3-mediated necroptosis which promote efficient pulmonary immune response. [PDF]
Adachi T +13 more
europepmc +1 more source
Erratum: Advances in RIPK1 kinase inhibitors
openaire +2 more sources
Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1. [PDF]
Liu R +14 more
europepmc +1 more source
SPOP mediates apoptosis and protects against necroptosis by regulating ubiquitination of RIPK1 and RIPK3. [PDF]
Ye Y +8 more
europepmc +1 more source
GADD45β inhibits RIPK3-mediated NF-κB activation by interfering with NEMO-RIPK1-RIPK3 interactions. [PDF]
Casale C +10 more
europepmc +1 more source

